EMTRIVA 10 mg/ml, oral solution bottle, 170 ml
Active ingredients: Emtricitabine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 170 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EMTRIVA 10 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) jaune(brun) polyéthylène téréphtalate de 170 ml avec gobelet(s) doseur(s) polypropylène avec fermeture de sécurité enfant
- Marketing authorisation holder
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Feb 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66717579CIP73634484CIP133400936344846Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EMTRICITABINEsolution | 10 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.